Temporarily Waive Patents On Covid Vaccines
- All
- News
-
Patent Waiver Talks For Covid Jabs Get Widespread Support At G7: Centre
- Monday June 14, 2021
- India News | Press Trust of India
A proposal by India and South Africa to temporarily waive patents on COVID-19 vaccines to ensure their equitable access received widespread support at the G7 summit in the UK, the Ministry of External Affairs said on Sunday.
- www.ndtv.com
-
BRICS Supports Vaccine Patent Waiver Plan Proposed By India, South Africa
- Wednesday June 2, 2021
- India News | Press Trust of India
In a significant move, the five-nation grouping BRICS on Tuesday supported a proposal by India and South Africa to temporarily waive patents on COVID-19 vaccines
- www.ndtv.com
-
Switzerland Looking At 'New Situation' As US Backs Covid Vaccines Patent Waiver
- Friday May 7, 2021
- India News | Press Trust of India
Switzerland on Friday said it is looking at the new situation arising out of the United States backing an initiative to temporarily waive patent rules for COVID-19 vaccines.
- www.ndtv.com
-
Patent Waiver Talks For Covid Jabs Get Widespread Support At G7: Centre
- Monday June 14, 2021
- India News | Press Trust of India
A proposal by India and South Africa to temporarily waive patents on COVID-19 vaccines to ensure their equitable access received widespread support at the G7 summit in the UK, the Ministry of External Affairs said on Sunday.
- www.ndtv.com
-
BRICS Supports Vaccine Patent Waiver Plan Proposed By India, South Africa
- Wednesday June 2, 2021
- India News | Press Trust of India
In a significant move, the five-nation grouping BRICS on Tuesday supported a proposal by India and South Africa to temporarily waive patents on COVID-19 vaccines
- www.ndtv.com
-
Switzerland Looking At 'New Situation' As US Backs Covid Vaccines Patent Waiver
- Friday May 7, 2021
- India News | Press Trust of India
Switzerland on Friday said it is looking at the new situation arising out of the United States backing an initiative to temporarily waive patent rules for COVID-19 vaccines.
- www.ndtv.com